• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于基因组的绝缘系统的合理设计有助于异源尿酸酶表达以治疗高尿酸血症。

Rational design of a genome-based insulated system in facilitates heterologous uricase expression for hyperuricemia treatment.

作者信息

He Lina, Tang Wei, Huang Ling, Zhou Wei, Huang Shaojia, Zou Linxuan, Yuan Lisha, Men Dong, Chen Shiyun, Hu Yangbo

机构信息

CAS Key Laboratory of Special Pathogens and Biosafety Wuhan Institute of Virology, Chinese Academy of Sciences Wuhan China.

University of Chinese Academy of Sciences Beijing China.

出版信息

Bioeng Transl Med. 2022 Nov 21;8(2):e10449. doi: 10.1002/btm2.10449. eCollection 2023 Mar.

DOI:10.1002/btm2.10449
PMID:36925686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10013758/
Abstract

Hyperuricemia is a prevalent disease worldwide that is characterized by elevated urate levels in the blood owing to purine metabolic disorders, which can result in gout and comorbidities. To facilitate the treatment of hyperuricemia through the uricolysis, we engineered a probiotic Nissle 1917 (EcN) named EcN C6 by inserting an FtsP-uricase cassette into an "insulated site" located between the and genes. Expression of FtsP-uricase in this insulated region did not influence the probiotic properties or global gene transcription of EcN but strongly increased the enzymatic activity for urate degeneration, suggesting that the genome-based insulated system is an ideal strategy for EcN modification. Oral administration of EcN C6 successfully alleviated hyperuricemia, related symptoms and gut microbiota in a purine-rich food-induced hyperuricemia rat model and a -knockout mouse model. Together, our study provides an insulated site for heterologous gene expression in EcN strain and a recombinant EcN C6 strain as a safe and effective therapeutic candidate for hyperuricemia treatment.

摘要

高尿酸血症是一种在全球范围内普遍存在的疾病,其特征是由于嘌呤代谢紊乱导致血液中尿酸水平升高,这可能会引发痛风及合并症。为了通过尿酸分解促进高尿酸血症的治疗,我们通过将FtsP-尿酸酶盒插入位于特定基因之间的“绝缘位点”,构建了一种名为EcN C6的益生菌Nissle 1917(EcN)。FtsP-尿酸酶在该绝缘区域的表达不影响EcN的益生菌特性或全局基因转录,但显著提高了尿酸降解的酶活性,这表明基于基因组的绝缘系统是EcN修饰的理想策略。在富含嘌呤食物诱导的高尿酸血症大鼠模型和特定基因敲除小鼠模型中,口服EcN C6成功缓解了高尿酸血症、相关症状及肠道微生物群。总之,我们的研究为EcN菌株中的异源基因表达提供了一个绝缘位点,并提供了重组EcN C6菌株作为治疗高尿酸血症的安全有效候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/3d1012f8fa2e/BTM2-8-e10449-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/7a84ce81f0f6/BTM2-8-e10449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/be72bfdec501/BTM2-8-e10449-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/078c065f8477/BTM2-8-e10449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/97029097ba3e/BTM2-8-e10449-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/0a0024a4caa1/BTM2-8-e10449-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/3d1012f8fa2e/BTM2-8-e10449-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/7a84ce81f0f6/BTM2-8-e10449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/be72bfdec501/BTM2-8-e10449-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/078c065f8477/BTM2-8-e10449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/97029097ba3e/BTM2-8-e10449-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/0a0024a4caa1/BTM2-8-e10449-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10a6/10013758/3d1012f8fa2e/BTM2-8-e10449-g005.jpg

相似文献

1
Rational design of a genome-based insulated system in facilitates heterologous uricase expression for hyperuricemia treatment.基于基因组的绝缘系统的合理设计有助于异源尿酸酶表达以治疗高尿酸血症。
Bioeng Transl Med. 2022 Nov 21;8(2):e10449. doi: 10.1002/btm2.10449. eCollection 2023 Mar.
2
A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy.一种稳定的肝脏特异性尿酸氧化酶基因敲除高尿酸血症小鼠模型发现激活的肝从头嘌呤合成和尿酸肾病。
Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167009. doi: 10.1016/j.bbadis.2023.167009. Epub 2024 Jan 17.
3
An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.一种工程化的大肠杆菌Nissle菌株可预防1型酪氨酸血症小鼠模型中的致死性肝损伤。
J Hepatol. 2024 Mar;80(3):454-466. doi: 10.1016/j.jhep.2023.10.037. Epub 2023 Nov 10.
4
Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden.使用绝缘基因组着陆垫和遗传回路重新设计用于苯丙酮尿症的大肠杆菌 Nissle 治疗方法,以减轻负担。
Cell Syst. 2023 Jun 21;14(6):512-524.e12. doi: 10.1016/j.cels.2023.05.004.
5
Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.尿酸氧化酶基因敲除为代谢紊乱相关高尿酸血症提供了稳定的小鼠模型。
Kidney Int. 2018 Jan;93(1):69-80. doi: 10.1016/j.kint.2017.04.031. Epub 2017 Jul 18.
6
Engineered Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment.工程化的 Nissle 1917 菌株,具有尿酸氧化酶和氧气回收系统,用于治疗高尿酸血症。
Gut Microbes. 2022 Jan-Dec;14(1):2070391. doi: 10.1080/19490976.2022.2070391.
7
Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder.工程化产生 5-HT 的肠道益生菌可改善胃肠道动力和行为障碍。
Front Cell Infect Microbiol. 2022 Oct 20;12:1013952. doi: 10.3389/fcimb.2022.1013952. eCollection 2022.
8
Effect of a specific strain on minimal/mild hepatic encephalopathy treatment.特定菌株对轻微/轻度肝性脑病治疗的影响。
World J Hepatol. 2022 Mar 27;14(3):634-646. doi: 10.4254/wjh.v14.i3.634.
9
Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic Strain Nissle 1917.开发全基因组代谢模型和益生菌菌株 1917 表型分析。
Int J Mol Sci. 2021 Feb 20;22(4):2122. doi: 10.3390/ijms22042122.
10
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis.构建可持续生产 3-羟基丁酸的益生菌大肠杆菌用于结肠炎治疗。
Cell Mol Immunol. 2021 Oct;18(10):2344-2357. doi: 10.1038/s41423-021-00760-2. Epub 2021 Sep 3.

引用本文的文献

1
Systematic Engineering for Efficient Uric Acid-Degrading Activity in Probiotic Yeast .益生菌酵母中高效尿酸降解活性的系统工程
ACS Synth Biol. 2025 Jun 20;14(6):2030-2043. doi: 10.1021/acssynbio.4c00831. Epub 2025 May 8.
2
Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study.昼夜节律紊乱中肠道微生物群的多组学评估:一项横断面临床研究
Front Cell Infect Microbiol. 2025 Mar 27;15:1524987. doi: 10.3389/fcimb.2025.1524987. eCollection 2025.
3
Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: A review.

本文引用的文献

1
Engineered Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment.工程化的 Nissle 1917 菌株,具有尿酸氧化酶和氧气回收系统,用于治疗高尿酸血症。
Gut Microbes. 2022 Jan-Dec;14(1):2070391. doi: 10.1080/19490976.2022.2070391.
2
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria.一种工程化的细菌疗法可降低临床前模型和肠道高草酸尿症的计算机模拟中的尿液草酸盐。
Mol Syst Biol. 2022 Mar;18(3):e10539. doi: 10.15252/msb.202110539.
3
Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus.
基于多组学技术的高尿酸血症肾病发病机制研究进展:综述
Medicine (Baltimore). 2024 Dec 20;103(51):e40975. doi: 10.1097/MD.0000000000040975.
4
Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice.工程益生菌大肠杆菌在小鼠中引发针对甲型流感病毒的即时和长期保护。
Nat Commun. 2024 Aug 9;15(1):6802. doi: 10.1038/s41467-024-51182-3.
5
Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions.探索底物-微生物相互作用:一种开发靶向共生组合的代谢共生方法。
Gut Microbes. 2024 Jan-Dec;16(1):2305716. doi: 10.1080/19490976.2024.2305716. Epub 2024 Feb 1.
血清尿酸的变化与糖尿病患者的肠道微生物群有关。
Front Cell Infect Microbiol. 2022 Jan 18;11:761757. doi: 10.3389/fcimb.2021.761757. eCollection 2021.
4
Self-Cascade Uricase/Catalase Mimics Alleviate Acute Gout.自级联尿酸酶/过氧化氢酶模拟物缓解急性痛风。
Nano Lett. 2022 Jan 12;22(1):508-516. doi: 10.1021/acs.nanolett.1c04454. Epub 2021 Dec 30.
5
Management of Gout.痛风的管理
JAMA. 2021 Dec 28;326(24):2519-2520. doi: 10.1001/jama.2021.19763.
6
Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut.铁载体介导的锌获取增强肠杆菌在炎症肠道中的定植。
Nat Commun. 2021 Dec 1;12(1):7016. doi: 10.1038/s41467-021-27297-2.
7
A Novel Cascade Nanoreactor Integrating Two-Dimensional Pd-Ru Nanozyme, Uricase and Red Blood Cell Membrane for Highly Efficient Hyperuricemia Treatment.一种新型级联纳米反应器,集成二维 Pd-Ru 纳米酶、尿酸酶和红细胞膜,用于高效高尿酸血症治疗。
Small. 2021 Nov;17(46):e2103645. doi: 10.1002/smll.202103645. Epub 2021 Oct 19.
8
Metabolic modulation of tumours with engineered bacteria for immunotherapy.利用工程菌对肿瘤进行代谢调节以进行免疫治疗。
Nature. 2021 Oct;598(7882):662-666. doi: 10.1038/s41586-021-04003-2. Epub 2021 Oct 6.
9
Metagenomic analysis revealed the potential role of gut microbiome in gout.宏基因组分析揭示了肠道微生物组在痛风中的潜在作用。
NPJ Biofilms Microbiomes. 2021 Aug 9;7(1):66. doi: 10.1038/s41522-021-00235-2.
10
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.一株工程化大肠杆菌 Nissle 治疗苯丙酮尿症的安全性和药效学:首次人体 1/2a 期研究。
Nat Metab. 2021 Aug;3(8):1125-1132. doi: 10.1038/s42255-021-00430-7. Epub 2021 Jul 22.